Search by Drug Name or NDC

    NDC 72789-0112-90 Bupropion Hydrochloride 300 mg/1 Details

    Bupropion Hydrochloride 300 mg/1

    Bupropion Hydrochloride is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PD-Rx Pharmaceuticals, Inc.. The primary component is BUPROPION HYDROCHLORIDE.

    Product Information

    NDC 72789-0112
    Product ID 72789-112_f8399515-a166-d537-e053-6394a90a9973
    Associated GPIs 58300040107530
    GCN Sequence Number 053007
    GCN Sequence Number Description bupropion HCl TAB ER 24H 300 MG ORAL
    HIC3 H7D
    HIC3 Description NOREPINEPHRINE AND DOPAMINE REUPTAKE INHIB (NDRIS)
    GCN 20318
    HICL Sequence Number 001653
    HICL Sequence Number Description BUPROPION HCL
    Brand/Generic Generic
    Proprietary Name Bupropion Hydrochloride
    Proprietary Name Suffix (XL)
    Non-Proprietary Name bupropion hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 300
    Active Ingredient Units mg/1
    Substance Name BUPROPION HYDROCHLORIDE
    Labeler Name PD-Rx Pharmaceuticals, Inc.
    Pharmaceutical Class Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA210081
    Listing Certified Through 2024-12-31

    Package

    NDC 72789-0112-90 (72789011290)

    NDC Package Code 72789-112-90
    Billing NDC 72789011290
    Package 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (72789-112-90)
    Marketing Start Date 2020-09-03
    NDC Exclude Flag N
    Pricing Information N/A